Elucidating the unusual reaction kinetics of D-glucuronyl C5-epimerase.
N-sulfoheparosan
2-O-sulfotransferase
C5-epimerase
divalent cations
enzyme kinetics
Journal
Glycobiology
ISSN: 1460-2423
Titre abrégé: Glycobiology
Pays: England
ID NLM: 9104124
Informations de publication
Date de publication:
21 10 2020
21 10 2020
Historique:
received:
20
03
2020
revised:
27
03
2020
accepted:
30
03
2020
pubmed:
19
4
2020
medline:
3
11
2021
entrez:
19
4
2020
Statut:
ppublish
Résumé
The chemoenzymatic synthesis of heparin, through a multienzyme process, represents a critical challenge in providing a safe and effective substitute for this animal-sourced anticoagulant drug. D-glucuronyl C5-epimerase (C5-epi) is an enzyme acting on a heparin precursor, N-sulfoheparosan, catalyzing the reversible epimerization of D-glucuronic acid (GlcA) to L-iduronic acid (IdoA). The absence of reliable assays for C5-epi has limited elucidation of the enzymatic reaction and kinetic mechanisms. Real time and offline assays are described that rely on 1D 1H NMR to study the activity of C5-epi. Apparent steady-state kinetic parameters for both the forward and the pseudo-reverse reactions of C5-epi are determined for the first time using polysaccharide substrates directly relevant to the chemoenzymatic synthesis and biosynthesis of heparin. The forward reaction shows unusual sigmoidal kinetic behavior, and the pseudo-reverse reaction displays nonsaturating kinetic behavior. The atypical sigmoidal behavior of the forward reaction was probed using a range of buffer additives. Surprisingly, the addition of 25 mM each of CaCl2 and MgCl2 resulted in a forward reaction exhibiting more conventional Michaelis-Menten kinetics. The addition of 2-O-sulfotransferase, the next enzyme involved in heparin synthesis, in the absence of 3'-phosphoadenosine 5'-phosphosulfate, also resulted in C5-epi exhibiting a more conventional Michaelis-Menten kinetic behavior in the forward reaction accompanied by a significant increase in apparent Vmax. This study provides critical information for understanding the reaction kinetics of C5-epi, which may result in improved methods for the chemoenzymatic synthesis of bioengineered heparin.
Identifiants
pubmed: 32304324
pii: 5822070
doi: 10.1093/glycob/cwaa035
pmc: PMC7581656
doi:
Substances chimiques
Iduronic Acid
3402-98-0
Glucuronic Acid
8A5D83Q4RW
Carbohydrate Epimerases
EC 5.1.3.-
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
847-858Subventions
Organisme : NCI NIH HHS
ID : U01 CA231074
Pays : United States
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
J Biol Chem. 2001 Jun 15;276(24):21538-43
pubmed: 11279150
J Biol Chem. 2015 Feb 20;290(8):4620-30
pubmed: 25568314
J Biol Chem. 2004 Apr 9;279(15):14631-8
pubmed: 14718527
Anal Biochem. 1999 Oct 1;274(1):131-7
pubmed: 10527506
Anal Bioanal Chem. 2011 Jul;401(1):237-44
pubmed: 21573838
J Biol Chem. 2012 Jun 15;287(25):20996-1002
pubmed: 22528493
ACS Chem Biol. 2015 Apr 17;10(4):1064-71
pubmed: 25594747
Appl Microbiol Biotechnol. 2011 Jul;91(1):91-9
pubmed: 21484210
Mol Cell. 2016 Jul 21;63(2):337-346
pubmed: 27425410
Glycobiology. 2000 Feb;10(2):159-71
pubmed: 10642607
Angew Chem Int Ed Engl. 2019 Apr 23;58(18):5962-5966
pubmed: 30870573
Carbohydr Polym. 2015 May 20;122:399-407
pubmed: 25817684
J Biol Chem. 2003 Dec 26;278(52):51975-84
pubmed: 14583616
Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):6760-6765
pubmed: 30872481
J Biol Chem. 2001 Jun 8;276(23):20069-77
pubmed: 11274177
J Biol Chem. 2010 Oct 29;285(44):34240-9
pubmed: 20729556
Bioeng Transl Med. 2017 Mar;2(1):17-30
pubmed: 28516163
J Am Chem Soc. 2019 Jul 24;141(29):11540-11556
pubmed: 31188575
Methods Mol Biol. 2015;1229:31-6
pubmed: 25325941
Anal Bioanal Chem. 2014 Jan;406(2):525-36
pubmed: 24271188
Adv Drug Deliv Rev. 2016 Feb 1;97:237-49
pubmed: 26555370
Curr Protoc Mol Biol. 2001 May;Chapter 17:Unit17.13B
pubmed: 18265142
J Am Chem Soc. 2008 Oct 1;130(39):12998-3007
pubmed: 18767845
J Med Chem. 2003 Jun 19;46(13):2551-64
pubmed: 12801218
Nat Prod Rep. 2009 Mar;26(3):313-21
pubmed: 19240943
Appl Microbiol Biotechnol. 2012 Jan;93(1):1-16
pubmed: 22048616
Anal Chem. 2014 Jan 7;86(1):326-30
pubmed: 24364596
Anal Biochem. 2010 Mar 15;398(2):275-7
pubmed: 20018166
Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):12984-9
pubmed: 11687650
J Biol Chem. 2018 Aug 31;293(35):13725-13735
pubmed: 29976758
Nat Chem Biol. 2006 Apr;2(4):195-6
pubmed: 16532012